COADMINISTRATION OF HETEROGENEOUS BIOPOLYMER HYDROGEL AND HYALURONIC ACID IN OSTEOARTHRITIS: THE FIRST EXPERIENCE

Download full text PDF
Issue: 
1
Year: 
2016

I. Solovyeva (1); Professor N. Shesternya (2), MD; N. Perova (4), Biol.D; Professor V. Sevastyanov (3,4), Biol.D 1 -Hospital, Research Center, Russian Academy of Sciences, Chernogolovka 2 -I.M. Sechenov First Moscow State Medical University 3 -Acad. V.I. Shumakov Center of Transplantology and Artificial Organs, Moscow 4 -Institute of Biomedical Studies and Technologies, Moscow

Comparative analysis of different treatment regimens for primary knee osteoarthritis demonstrated the efficacy of the combined intraarticular administration of heterogeneous biopolymer hydrogel and a hyaluronic acid preparation, which was best in terms of all indicators. The duration of the followup was 12 months.
Keywords: 
knee osteoarthritis
hyaluronic acid
composition of heterogeneous biopolymer hydrogel
intraarticular administration

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Brandt K., Doherty M., Lohmander L. Osteoarthritis / Oxford: Oxford University Press; 1998; 22 p.
  2. Karateev A.E. Obladajut li neste roidnye protivovospalitel'nye pre-paraty patogeneticheskim dejstviem? // Sovremennaja revmatologija. – 2012; 4: 13–22.
  3. Vrandt K. The mechanism of action of nonsteroidal anti–inflammatory drugs . // J. Rheum. – 1991; 18: 120–1.
  4. Doherty M. «Condor-protection» by nonsteroidal anti–inflammatory drugs // Ann. Rheum. Dis. – 1989; 48: 619–21.
  5. Ostensen M. Cartilage changes in arthritis do non–steroidal antiphlogistics have positive or negative effects? // Tiddsskr. Nor. Laegeforen. – 1991; 111: 838–40.
  6. Elimination of stabilized hyaluronan from the knee joint in healthy men // Clin. Pharmacokinet. – 2002; 41: 603–13.
  7. Smith M., Ghosh P. The synthesis of hyaluronic acid by human synovial fibroblasts is influenced by the nature of the hyaluronate in the extracellular environment // Rheumatol. Int. – 1987; 7: 113–22.
  8. Weissman B. The structure of hyalobiuronic acid and hyaluronic acid from umbilical cord // J. Am. Chem. Soc. – 1954; 76: 1753–7.
  9. Saari H. et al. Differential effects of reactive oxygen species on native synovial fluid and purified human umbilical cord hyaluronate // Inflammation. – 1993; 17: 403–15.
  10. Sevast'janov V.I., Perova N.V., Nemets E.A. i dr. Primery eksperimental'no-klinicheskogo primenenija biosovmestimyh materialov v regenerativnoj meditsine. V kn.: V.I. Sevast'janov, M.P. Kirpichnikov. Biosovmestimye materialy / M.: OOO Meditsinskoe informatsionnoe agent-stvo, 2011; 237–52 s.
  11. Sevastianov V., Lubyako A., Perova N. et al. First trial usage of the biodegradable matrix Sphero®GEL in the reconstructive surgery. Advanced Materials / M., 2007; V.1-S: 147–52 p.
  12. Sevastianov V., Vasilets V., Agapov I. Biopolymer implants for hightechnology assistance in the field of replacement and regenerative medicine // Rare metals. – 2009; 28: 84–6.Primenenie in'ektsionnyh form biopolimernyh geterogennyh gidro-13. gelej pri degenerativno-distroficheskih porazhenijah sustavov. Prakticheskoe posobie dlja vrachej / M.: OOO Izdatel'stvo Triada, 2012; 27 s.
  13. Sajkovskij R.S., Savenkova N.A., Aver'janov A.V. i dr. Effektivnost' primenenija preparata Sferogel' dlja lechenija gonartroza // Klinicheskaja praktika. – 2013; 3: 4–10.
  14. Zajtsev V.M., Lifljandskij V.G., Marinkin V.I. Prikladnaja meditsin skaja statistika // SPb: OOO «Foliant», 2003; 432 s.
  15. Osnovy epidemiologii i statisticheskogo analiza v obschestvennom . zdorov'e i upravlenii zdravoohraneniem. Kafedra obschestvennogo zdravo-ohranenija s kursom profilakticheskoj meditsiny Moskovskoj meditsinskoj akademii im. I.M.Sechenova / M.: 2003, 59 s.
  16. Stanton A. Glantz. Primer of Biostatistics. Fourth edition, McGROW-HILL 17. Health Professions Division / New York St, 1998; 459 r.
  17. Chichasova NV. Preparaty gialuronovoj kisloty v lechenii osteoartro Sinvisk (gilan G-F 20): effektivnost' i bezopasnost' // Sovremennaja revmatol. – 2013; 4: 85–91.
  18. Huskisson E., Donnelly S. Gialuronovaja kislota v lechenii osteoartroza 19. kolennogo sustava // Revmatologija. – 1999; 38: 602–7.
  19. Wobig M., Dickhut A., Maier R. et al. Viscosupplementation with hylan G-F 20. 20: a 26-week controlled trial on efficacy and safety in the osteoarthritis knee // Clin. Ther. – 1998; 20 (3): 410–23.